Insights From Pharma 2025: Harnessing AI: Revolutionizing Drug Discovery And Early Disease Detection

What are the real-world implications of artificial intelligence for the future of medicine? At the Pharma 2025 conference, Cencora engaged with leading minds in the pharmaceutical sector to uncover the answers. Among the most compelling discussions was the exchange between Jörg Schüttrumpf, Chief Scientific Innovation Officer at Grifols, and Poka Cui, Director at Vintura, part of Cencora. Their conversation illuminated the practical ways AI is already revolutionizing drug discovery and offering new hope for early disease detection.

Gain invaluable insights from these experts on the cutting edge of pharmaceutical innovation – read the full article now.